BCL2 and melanoma: Moreover, treatment with a specific inhibitor of Bcl-2 induced downregulation of miR-378a-5p in melanoma cells, thus indicating that pharmacologic inhibition of Bcl-2 could exert its effect also through modulation of miR-378a-5p functions.